Targeting inflammation and immunity in pulmonary arterial hypertension: any easier after the CANTOS proof-of-concept that anti-inflammation cuts cardiovascular events?
Pulm Circ. 2018 Jan-Mar;8(1):2045893218754855.
doi: 10.1177/2045893218754855.
Epub 2018 Jan 8.